{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:04:13Z","timestamp":1790748253640,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS110694"],"award-info":[{"award-number":["R01NS110694"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS197387"],"award-info":[{"award-number":["R01 NS197387"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 MH119355"],"award-info":[{"award-number":["R01 MH119355"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS108686"],"award-info":[{"award-number":["R01 NS108686"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P31 EB027061"],"award-info":[{"award-number":["P31 EB027061"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["SAF2009-08233"],"award-info":[{"award-number":["SAF2009-08233"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-096322-B-100"],"award-info":[{"award-number":["RTI2018-096322-B-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease (HD) is a neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the\n                    <jats:italic>HTT<\/jats:italic>\n                    gene for which no therapies are available.\n                    <jats:italic>HTT<\/jats:italic>\n                    mutation causes protein misfolding and aggregation, preferentially affecting medium spiny neurons (MSNs) of the basal ganglia. Transcriptional perturbations in synaptic genes and neuroinflammation are key processes that precede MSN dysfunction and motor symptom onset. Understanding the interplay between these processes is crucial to develop effective therapeutic strategies to treat HD. We investigated the role of protein kinase CK2\u03b1\u2019, a kinase upregulated in MSNs in HD and previously associated with Parkinson\u2019s disease (PD), in the regulation of neuroinflammation and synaptic function in HD. We used the heterozygous knock-in zQ175 HD mouse model and compared that to zQ175 mice lacking one allele of CK2\u03b1\u2019 (zQ175:CK2\u03b1\u2019\n                    <jats:sup>(\u00b1)<\/jats:sup>\n                    ). CK2\u03b1\u2019 haploinsufficiency in zQ175 mice resulted in decreased levels of pro-inflammatory cytokines, HTT aggregation, astrogliosis and transcriptional alterations of synaptic genes related to glutamatergic signaling. zQ175:CK2\u03b1\u2019\n                    <jats:sup>(\u00b1)<\/jats:sup>\n                    mice also presented increased frequency of striatal miniature excitatory postsynaptic currents (mEPSCs), an indicator of synaptic activity, and improved motor coordination compared to zQ175 mice. Neuropathological and phenotypic changes mediated by CK2\u03b1\u2019 were connected to alpha-synuclein (\u03b1-syn) dysregulation and correlated with differences in \u03b1-syn serine 129 phosphorylation (pS129-\u03b1-syn), a post-translational modification involved in \u03b1-synucleinopathy and shown to be regulated by CK2 in PD. pS129-\u03b1-syn was increased in the nuclei of MSNs in zQ175 mice and in the striatum of patients with HD, and it decreased in zQ175:CK2\u03b1\u2019\n                    <jats:sup>(\u00b1)<\/jats:sup>\n                    mice. Collectively, our data established a novel connection between CK2\u03b1\u2019, neuroinflammation and synaptic gene dysregulation with synucleinopathy in HD and suggested common molecular mechanisms of neurodegeneration between HD and PD. Our results also support CK2\u03b1\u2019 inhibition as a potential therapeutic strategy to modulate neuronal function and neuroprotection in HD.\n                  <\/jats:p>","DOI":"10.1186\/s40478-022-01379-8","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:03:45Z","timestamp":1654236225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington\u2019s disease"],"prefix":"10.1186","volume":"10","author":[{"given":"Dahyun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De\u2019jah","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Nanclares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cuccu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny S.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor G.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Mansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Nichols-Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gundry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tomas-Zapico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Benneyworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclin","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Cvetanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Araque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-5462","authenticated-orcid":false,"given":"Rocio","family":"Gomez-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"publisher","unstructured":"The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-e","DOI":"10.1016\/0092-8674(93)90585-e"},{"key":"1379_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah O, Sosunov AA, Shaik A, Ofori K, Liu Y, Vonsattel JP, Adorjan I, Menon V, Goldman JE (2020) Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol Commun 8:19. https:\/\/doi.org\/10.1186\/s40478-020-0880-6","journal-title":"Acta Neuropathol Commun"},{"key":"1379_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","volume":"28","author":"P Arlotta","year":"2008","unstructured":"Arlotta P, Molyneaux BJ, Jabaudon D, Yoshida Y, Macklis JD (2008) Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J Neurosci 28:622\u2013632. https:\/\/doi.org\/10.1523\/JNEUROSCI.2986-07.2008","journal-title":"J Neurosci"},{"key":"1379_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nchembio.582","volume":"7","author":"RS Atwal","year":"2011","unstructured":"Atwal RS, Desmond CR, Caron N, Maiuri T, Xia J, Sipione S, Truant R (2011) Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol 7:453\u2013460. https:\/\/doi.org\/10.1038\/nchembio.582","journal-title":"Nat Chem Biol"},{"key":"1379_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron 79:1044\u20131066. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004","journal-title":"Neuron"},{"key":"1379_CR6","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/srep03460","volume":"3","author":"Y Bian","year":"2013","unstructured":"Bian Y, Ye M, Wang C, Cheng K, Song C, Dong M, Pan Y, Qin H, Zou H (2013) Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow. SciRep 3:3460. https:\/\/doi.org\/10.1038\/srep03460","journal-title":"SciRep"},{"key":"1379_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","volume":"6","author":"C Borgo","year":"2021","unstructured":"Borgo C, D\u2019Amore C, Sarno S, Salvi M, Ruzzene M (2021) Protein kinase CK2: a potential therapeutic target for diverse human diseases. Signal Transduct Target Ther 6:183. https:\/\/doi.org\/10.1038\/s41392-021-00567-7","journal-title":"Signal Transduct Target Ther"},{"key":"1379_CR8","doi-asserted-by":"publisher","first-page":"E7081","DOI":"10.1073\/pnas.1801772115","volume":"115","author":"LE Bowie","year":"2018","unstructured":"Bowie LE, Maiuri T, Alpaugh M, Gabriel M, Arbez N, Galleguillos D, Hung CLK, Patel S, Xia J, Hertz NT, Ross CA, Litchfield DW, Sipione S, Truant R (2018) N6-Furfuryladenine is protective in Huntington\u2019s disease models by signaling huntingtin phosphorylation. Proc Natl Acad Sci U S A 115:E7081\u2013E7090. https:\/\/doi.org\/10.1073\/pnas.1801772115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1379_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroscience.2020.01.037","volume":"431","author":"M Breza","year":"2020","unstructured":"Breza M, Emmanouilidou E, Leandrou E, Kartanou C, Bougea A, Panas M, Stefanis L, Karadima G, Vekrellis K, Koutsis G (2020) Elevated serum \u03b1-synuclein levels in huntington\u2019s disease patients. Neuroscience 431:34\u201339. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.01.037","journal-title":"Neuroscience"},{"key":"1379_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123527","author":"N Carty","year":"2015","unstructured":"Carty N, Berson N, Tillack K, Thiede C, Scholz D, Kottig K, Sedaghat Y, Gabrysiak C, Yohrling G, von der Kammer H, Ebneth A, Mack V, Munoz-Sanjuan I, Kwak S (2015) Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington\u2019s disease: an in vivo high-content imaging study. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0123527","journal-title":"PLoS ONE"},{"key":"1379_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph10010007","author":"J Castello","year":"2017","unstructured":"Castello J, Ragnauth A, Friedman E, Rebholz H (2017) CK2-an emerging target for neurological and psychiatric disorders. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph10010007","journal-title":"Pharmaceuticals (Basel)"},{"key":"1379_CR12","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1523\/JNEUROSCI.2369-19.2020","volume":"40","author":"A Cavaccini","year":"2020","unstructured":"Cavaccini A, Durkee C, Kofuji P, Tonini R, Araque A (2020) Astrocyte signaling gates long-term depression at corticostriatal synapses of the direct pathway. J Neurosci 40:5757\u20135768. https:\/\/doi.org\/10.1523\/JNEUROSCI.2369-19.2020","journal-title":"J Neurosci"},{"key":"1379_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-011-0963-6","volume":"356","author":"I Ceglia","year":"2011","unstructured":"Ceglia I, Flajolet M, Rebholz H (2011) Predominance of CK2\u03b1 over CK2\u03b1\u2019 in the mammalian brain. Mol Cell Biochem 356:169\u2013175. https:\/\/doi.org\/10.1007\/s11010-011-0963-6","journal-title":"Mol Cell Biochem"},{"key":"1379_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0304-3940(00)01247-7","volume":"289","author":"V Charles","year":"2000","unstructured":"Charles V, Mezey E, Reddy PH, Dehejia A, Young TA, Polymeropoulos MH, Brownstein MJ, Tagle DA (2000) Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington\u2019s disease patients and transgenic mouse models. Neurosci Lett 289:29\u201332. https:\/\/doi.org\/10.1016\/s0304-3940(00)01247-7","journal-title":"Neurosci Lett"},{"key":"1379_CR15","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1523\/JNEUROSCI.0546-04.2004","volume":"24","author":"HJ Chung","year":"2004","unstructured":"Chung HJ, Huang YH, Lau LF, Huganir RL (2004) Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 24:10248\u201310259. https:\/\/doi.org\/10.1523\/JNEUROSCI.0546-04.2004","journal-title":"J Neurosci"},{"key":"1379_CR16","doi-asserted-by":"publisher","unstructured":"Consortium GMoHsDG-H 2015 Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell 162:516-526, https:\/\/doi.org\/10.1016\/j.cell.2015.07.003","DOI":"10.1016\/j.cell.2015.07.003"},{"key":"1379_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/hmg\/ddr477","volume":"21","author":"S Corrochano","year":"2012","unstructured":"Corrochano S, Renna M, Carter S, Chrobot N, Kent R, Stewart M, Cooper J, Brown SD, Rubinsztein DC, Acevedo-Arozena A (2012) \u03b1-Synuclein levels modulate Huntington\u2019s disease in mice. Hum Mol Genet 21:485\u2013494. https:\/\/doi.org\/10.1093\/hmg\/ddr477","journal-title":"Hum Mol Genet"},{"key":"1379_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4161\/auto.19259","volume":"8","author":"S Corrochano","year":"2012","unstructured":"Corrochano S, Renna M, Tomas-Zapico C, Brown SD, Lucas JJ, Rubinsztein DC, Acevedo-Arozena A (2012) \u03b1-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology. Autophagy 8:431\u2013432. https:\/\/doi.org\/10.4161\/auto.19259","journal-title":"Autophagy"},{"key":"1379_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","volume":"36","author":"A Crotti","year":"2015","unstructured":"Crotti A, Glass CK (2015) The choreography of neuroinflammation in Huntington\u2019s disease. Trends Immunol 36:364\u2013373. https:\/\/doi.org\/10.1016\/j.it.2015.04.007","journal-title":"Trends Immunol"},{"key":"1379_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fnbeh.2015.00361","volume":"9","author":"PC Curtin","year":"2015","unstructured":"Curtin PC, Farrar AM, Oakeshott S, Sutphen J, Berger J, Mazzella M, Cox K, He D, Alosio W, Park LC, Howland D, Brunner D (2015) Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD. Front Behav Neurosci 9:361. https:\/\/doi.org\/10.3389\/fnbeh.2015.00361","journal-title":"Front Behav Neurosci"},{"key":"1379_CR21","first-page":"62","volume-title":"Huntington's disease","author":"D Craufurd","year":"2002","unstructured":"Craufurd D, Snowden J (2002) Neuropsychological and neuropsychiatric aspects of huntington\u2019s disease. In: Bates G, Harper PS, Jones L (eds) Huntington\u2019s disease. Oxford University Press, Oxford, pp 62\u201394"},{"key":"1379_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100910","author":"D Davidi","year":"2020","unstructured":"Davidi D, Schechter M, Elhadi SA, Matatov A, Nathanson L, Sharon R (2020) \u03b1-synuclein translocates to the nucleus to activate retinoic-acid-dependent gene transcription. iScience. https:\/\/doi.org\/10.1016\/j.isci.2020.100910","journal-title":"iScience"},{"key":"1379_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004676","author":"M Decressac","year":"2012","unstructured":"Decressac M, Kadkhodaei B, Mattsson B, Laguna A, Perlmann T, Bj\u00f6rklund A (2012) \u03b1-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3004676","journal-title":"Sci Transl Med"},{"key":"1379_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8546","author":"B Diaz-Castro","year":"2019","unstructured":"Diaz-Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS (2019) Astrocyte molecular signatures in Huntington\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw8546","journal-title":"Sci Transl Med"},{"key":"1379_CR25","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993. https:\/\/doi.org\/10.1126\/science.277.5334.1990","journal-title":"Science"},{"key":"1379_CR26","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s00018-009-9153-z","volume":"66","author":"I Dominguez","year":"2009","unstructured":"Dominguez I, Sonenshein GE, Seldin DC (2009) Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer. Cell Mol Life Sci 66:1850\u20131857. https:\/\/doi.org\/10.1007\/s00018-009-9153-z","journal-title":"Cell Mol Life Sci"},{"key":"1379_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104119118","author":"MC Dorst","year":"2021","unstructured":"Dorst MC, D\u00edaz-Moreno M, Dias DO, Guimar\u00e3es EL, Holl D, Kalkitsas J, Silberberg G, G\u00f6ritz C (2021) Astrocyte-derived neurons provide excitatory input to the adult striatal circuitry. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2104119118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1379_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1471-4159.2007.05016.x","volume":"104","author":"MM Fan","year":"2008","unstructured":"Fan MM, Zhang H, Hayden MR, Pelech SL, Raymond LA (2008) Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors. J Neurochem 104:790\u2013805. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05016.x","journal-title":"J Neurochem"},{"key":"1379_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fern\u00e1ndez-Nogales","year":"2014","unstructured":"Fern\u00e1ndez-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, Hern\u00e1ndez F, Avila J, Lucas JJ (2014) Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881\u2013885. https:\/\/doi.org\/10.1038\/nm.3617","journal-title":"Nat Med"},{"key":"1379_CR30","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","volume":"11","author":"RJ Ferrante","year":"1991","unstructured":"Ferrante RJ, Kowall NW, Richardson EP (1991) Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 11:3877\u20133887. https:\/\/doi.org\/10.1523\/JNEUROSCI.11-12-03877.1991","journal-title":"J Neurosci"},{"key":"1379_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1126\/science.281.5378.838","volume":"281","author":"AA Fienberg","year":"1998","unstructured":"Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O\u2019Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838\u2013842. https:\/\/doi.org\/10.1126\/science.281.5378.838","journal-title":"Science"},{"key":"1379_CR32","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00018-017-2705-8","volume":"75","author":"C Franchin","year":"2018","unstructured":"Franchin C, Borgo C, Cesaro L, Zaramella S, Vilardell J, Salvi M, Arrigoni G, Pinna LA (2018) Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells. Cell Mol Life Sci 75:2011\u20132026. https:\/\/doi.org\/10.1007\/s00018-017-2705-8","journal-title":"Cell Mol Life Sci"},{"key":"1379_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"1379_CR34","doi-asserted-by":"publisher","first-page":"18696","DOI":"10.1038\/s41598-019-55177-9","volume":"9","author":"A Gallardo-Orihuela","year":"2019","unstructured":"Gallardo-Orihuela A, Herv\u00e1s-Corpi\u00f3n I, Hierro-Bujalance C, Sanchez-Sotano D, Jim\u00e9nez-G\u00f3mez G, Mora-L\u00f3pez F, Campos-Caro A, Garcia-Alloza M, Valor LM (2019) Transcriptional correlates of the pathological phenotype in a Huntington\u2019s disease mouse model. Sci Rep 9:18696. https:\/\/doi.org\/10.1038\/s41598-019-55177-9","journal-title":"Sci Rep"},{"key":"1379_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddac035","author":"HM Geertsma","year":"2022","unstructured":"Geertsma HM, Suk TR, Ricke KM, Horsthuis K, Parmasad JA, Fisk ZA, Callaghan SM, Rousseaux MWC (2022) Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddac035","journal-title":"Hum Mol Genet"},{"key":"1379_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.it.2017.12.002","volume":"39","author":"SA Gibson","year":"2018","unstructured":"Gibson SA, Benveniste EN (2018) Protein kinase CK2: an emerging regulator of immunity. Trends Immunol 39:82\u201385. https:\/\/doi.org\/10.1016\/j.it.2017.12.002","journal-title":"Trends Immunol"},{"key":"1379_CR37","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1038\/ncomms14405","volume":"8","author":"R Gomez-Pastor","year":"2017","unstructured":"Gomez-Pastor R, Burchfiel ET, Neef DW, Jaeger AM, Cabiscol E, McKinstry SU, Doss A, Aballay A, Lo DC, Akimov SS, Ross CA, Eroglu C, Thiele DJ (2017) Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington\u2019s disease. Nat Commun 8:14405. https:\/\/doi.org\/10.1038\/ncomms14405","journal-title":"Nat Commun"},{"key":"1379_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.73","author":"R Gomez-Pastor","year":"2018","unstructured":"Gomez-Pastor R, Burchfiel ET, Thiele DJ (2018) Regulation of heat shock transcription factors and their roles in physiology and disease. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/nrm.2017.73","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1379_CR39","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/S0021-9258(17)41790-X","volume":"269","author":"JA Greenwood","year":"1994","unstructured":"Greenwood JA, Scott CW, Spreen RC, Caputo CB, Johnson GV (1994) Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. J Biol Chem 269:4373\u20134380. https:\/\/doi.org\/10.1016\/S0021-9258(17)41790-X","journal-title":"J Biol Chem"},{"key":"1379_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtim\u00e4ki K, Vartiainen N, Puoliv\u00e4li J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrj\u00e4nheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7:e50717. https:\/\/doi.org\/10.1371\/journal.pone.0050717","journal-title":"PLoS ONE"},{"key":"1379_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.febslet.2011.11.019","volume":"586","author":"F Herrera","year":"2012","unstructured":"Herrera F, Outeiro TF (2012) \u03b1-Synuclein modifies huntingtin aggregation in living cells. FEBS Lett 586:7\u201312. https:\/\/doi.org\/10.1016\/j.febslet.2011.11.019","journal-title":"FEBS Lett"},{"key":"1379_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.792652","volume":"15","author":"S Hirschberg","year":"2021","unstructured":"Hirschberg S, Dvorzhak A, Rasooli-Nejad SMA, Angelov S, Kirchner M, Mertins P, L\u00e4ttig-T\u00fcnnemann G, Harms C, Schmitz D, Grantyn R (2021) Uncoupling the excitatory amino acid transporter 2 from its C-terminal interactome restores synaptic glutamate clearance at corticostriatal synapses and alleviates mutant huntingtin-induced hypokinesia. Front Cell Neurosci 15:792652. https:\/\/doi.org\/10.3389\/fncel.2021.792652","journal-title":"Front Cell Neurosci"},{"key":"1379_CR43","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","volume":"23","author":"HY Hsiao","year":"2014","unstructured":"Hsiao HY, Chiu FL, Chen CM, Wu YR, Chen HM, Chen YC, Kuo HC, Chern Y (2014) Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease. Hum Mol Genet 23:4328\u20134344. https:\/\/doi.org\/10.1093\/hmg\/ddu151","journal-title":"Hum Mol Genet"},{"key":"1379_CR44","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1152\/jn.01056.2014","volume":"113","author":"T Indersmitten","year":"2015","unstructured":"Indersmitten T, Tran CH, Cepeda CT, Levine MS (2015) Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the q175 mouse model of huntington\u2019s disease. J Neurophysiol 113:2953\u20132966. https:\/\/doi.org\/10.1152\/jn.01056.2014","journal-title":"J Neurophysiol"},{"key":"1379_CR45","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1074\/jbc.C800206200","volume":"284","author":"KJ Inglis","year":"2009","unstructured":"Inglis KJ, Chereau D, Brigham EF, Chiou SS, Sch\u00f6bel S, Frigon NL, Yu M, Caccavello RJ, Nelson S, Motter R, Wright S, Chian D, Santiago P, Soriano F, Ramos C, Powell K, Goldstein JM, Babcock M, Yednock T, Bard F, Basi GS, Sham H, Chilcote TJ, McConlogue L, Griswold-Prenner I, Anderson JP (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284:2598\u20132602. https:\/\/doi.org\/10.1074\/jbc.C800206200","journal-title":"J Biol Chem"},{"key":"1379_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Latz E, Bu\u00e9e L, Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"key":"1379_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"1379_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R (2017) Unravelling and exploiting astrocyte dysfunction in huntington\u2019s disease. Trends Neurosci 40:422\u2013437. https:\/\/doi.org\/10.1016\/j.tins.2017.05.002","journal-title":"Trends Neurosci"},{"key":"1379_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, Lu XH, Ramos EM, El-Zein K, Zhao Y, Deverasetty S, Tebbe A, Schaab C, Lavery DJ, Howland D, Kwak S, Botas J, Aaronson JS, Rosinski J, Coppola G, Horvath S, Yang XW (2016) Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat Neurosci 19:623\u2013633. https:\/\/doi.org\/10.1038\/nn.4256","journal-title":"Nat Neurosci"},{"key":"1379_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinfo 9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","journal-title":"BMC Bioinfo"},{"key":"1379_CR51","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1074\/jbc.M312760200","volume":"279","author":"G Lee","year":"2004","unstructured":"Lee G, Tanaka M, Park K, Lee SS, Kim YM, Junn E, Lee SH, Mouradian MM (2004) Casein kinase II-mediated phosphorylation regulates alpha-synuclein\/synphilin-1 interaction and inclusion body formation. J Biol Chem 279:6834\u20136839. https:\/\/doi.org\/10.1074\/jbc.M312760200","journal-title":"J Biol Chem"},{"key":"1379_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"key":"1379_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20021469","volume":"369","author":"DW Litchfield","year":"2003","unstructured":"Litchfield DW (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369:1\u201315. https:\/\/doi.org\/10.1042\/BJ20021469","journal-title":"Biochem J"},{"key":"1379_CR54","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1038\/s41598-020-60777-x","volume":"10","author":"P Liu","year":"2020","unstructured":"Liu P, Smith BR, Montonye ML, Kemper LJ, Leinonen-Wright K, Nelson KM, Higgins L, Guerrero CR, Markowski TW, Zhao X, Petersen AJ, Knopman DS, Petersen RC, Ashe KH (2020) A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals. Sci Rep 10:3869. https:\/\/doi.org\/10.1038\/s41598-020-60777-x","journal-title":"Sci Rep"},{"key":"1379_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269. https:\/\/doi.org\/10.1126\/science.287.5456.1265","journal-title":"Science"},{"key":"1379_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC, Ramboz S, Howland D (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7:e49838. https:\/\/doi.org\/10.1371\/journal.pone.0049838","journal-title":"PLoS ONE"},{"key":"1379_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.fe74c94bdd446a0470f6f905a30b5dd1","author":"S Oakeshott","year":"2013","unstructured":"Oakeshott S, Farrar A, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Howland D, Brunner D (2013) Deficits in a simple visual Go\/no-go discrimination task in two mouse models of huntington\u2019s disease. PLoS Curr. https:\/\/doi.org\/10.1371\/currents.hd.fe74c94bdd446a0470f6f905a30b5dd1","journal-title":"PLoS Curr"},{"key":"1379_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","volume":"6","author":"A Oueslati","year":"2016","unstructured":"Oueslati A (2016) Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? J Parkinsons Dis 6:39\u201351. https:\/\/doi.org\/10.3233\/JPD-160779","journal-title":"J Parkinsons Dis"},{"key":"1379_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148839","volume":"11","author":"Q Peng","year":"2016","unstructured":"Peng Q, Wu B, Jiang M, Jin J, Hou Z, Zheng J, Zhang J, Duan W (2016) Characterization of Behavioral, neuropathological, brain metabolic and key molecular changes in Zq175 knock-in mouse model Of huntington\u2019s disease. PLoS ONE 11:e0148839. https:\/\/doi.org\/10.1371\/journal.pone.0148839","journal-title":"PLoS ONE"},{"key":"1379_CR60","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1242\/jcs.00074","volume":"115","author":"LA Pinna","year":"2002","unstructured":"Pinna LA (2002) Protein kinase CK2: a challenge to canons. J Cell Sci 115:3873\u20133878. https:\/\/doi.org\/10.1242\/jcs.00074","journal-title":"J Cell Sci"},{"key":"1379_CR61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","volume":"100","author":"M Riessland","year":"2017","unstructured":"Riessland M, Kaczmarek A, Schneider S, Swoboda KJ, L\u00f6hr H, Bradler C, Grysko V, Dimitriadi M, Hosseinibarkooie S, Torres-Benito L, Peters M, Upadhyay A, Biglari N, Kr\u00f6ber S, H\u00f6lker I, Garbes L, Gilissen C, Hoischen A, N\u00fcrnberg G, N\u00fcrnberg P, Walter M, Rigo F, Bennett CF, Kye MJ, Hart AC, Hammerschmidt M, Kloppenburg P, Wirth B (2017) Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis. Am J Hum Genet 100:297\u2013315. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.005","journal-title":"Am J Hum Genet"},{"key":"1379_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0470-x","author":"AF Rosenberger","year":"2016","unstructured":"Rosenberger AF, Morrema TH, Gerritsen WH, van Haastert ES, Snkhchyan H, Hilhorst R, Rozemuller AJ, Scheltens P, van der Veries SM, Hoozemans JJ (2016) Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer\u2019s disease pathology. J Neuroinflam. https:\/\/doi.org\/10.1186\/s12974-015-0470-x","journal-title":"J Neuroinflam"},{"key":"1379_CR63","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19809","author":"MW Rousseaux","year":"2016","unstructured":"Rousseaux MW, de Haro M, Lasagna-Reeves CA, De Maio A, Park J, Jafar-Nejad P, Al-Ramahi I, Sharma A, See L, Lu N, Vilanova-Velez L, Klisch TJ, Westbrook TF, Troncoso JC, Botas J, Zoghbi HY (2016) TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. Elife. https:\/\/doi.org\/10.7554\/eLife.19809","journal-title":"Elife"},{"key":"1379_CR64","doi-asserted-by":"publisher","unstructured":"Schaffner SL, Wassouf Z, Lazaro DF, Xylaki M, Gladish N, Lin DT, MacIsaac J, Ramadori K, Schulze-Hentrich JM, Outeiro TF, Kobor MS (2021) Alpha-synuclein induces epigenomic dysregulation of glutamate signaling and locomotor pathways. bioRxiv. doi:https:\/\/doi.org\/10.1101\/2021.06.12.448150","DOI":"10.1101\/2021.06.12.448150"},{"key":"1379_CR65","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.neuron.2010.08.011","volume":"67","author":"A Sanz-Clemente","year":"2010","unstructured":"Sanz-Clemente A, Matta JA, Isaac JT, Roche KW (2010) Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron 67:984\u2013996. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.011","journal-title":"Neuron"},{"key":"1379_CR66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00109-008-0352-0","volume":"86","author":"NN Singh","year":"2008","unstructured":"Singh NN, Ramji DP (2008) Protein kinase CK2, an important regulator of the inflammatory response? J Mol Med (Berl) 86:887\u2013897. https:\/\/doi.org\/10.1007\/s00109-008-0352-0","journal-title":"J Mol Med (Berl)"},{"key":"1379_CR67","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.14723","volume":"150","author":"AI Smith-Dijak","year":"2019","unstructured":"Smith-Dijak AI, Sepers MD, Raymond LA (2019) Alterations in synaptic function and plasticity in Huntington disease. J Neurochem 150:346\u2013365. https:\/\/doi.org\/10.1111\/jnc.14723","journal-title":"J Neurochem"},{"key":"1379_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.exger.2016.04.023","volume":"81","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Ohsawa I, Shirasawa T, Takahashi M (2016) Early-onset motor impairment and increased accumulation of phosphorylated \u03b1-synuclein in the motor cortex of normal aging mice are ameliorated by coenzyme Q. Exp Gerontol 81:65\u201375. https:\/\/doi.org\/10.1016\/j.exger.2016.04.023","journal-title":"Exp Gerontol"},{"key":"1379_CR69","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","volume":"32","author":"I Tkac","year":"2012","unstructured":"Tkac I, Henry PG, Zacharoff L, Wedel M, Gong W, Deelchand DK, Li T, Dubinsky JM (2012) Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease. J Cereb Blood Flow Metab 32:1977\u20131988. https:\/\/doi.org\/10.1038\/jcbfm.2012.104","journal-title":"J Cereb Blood Flow Metab"},{"key":"1379_CR70","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/hmg\/ddr507","volume":"21","author":"C Tom\u00e1s-Zapico","year":"2012","unstructured":"Tom\u00e1s-Zapico C, D\u00edez-Zaera M, Ferrer I, G\u00f3mez-Ramos P, Mor\u00e1n MA, Miras-Portugal MT, D\u00edaz-Hern\u00e1ndez M, Lucas JJ (2012) \u03b1-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington\u2019s disease. Hum Mol Genet 21:495\u2013510. https:\/\/doi.org\/10.1093\/hmg\/ddr507","journal-title":"Hum Mol Genet"},{"key":"1379_CR71","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1172\/JCI120616","volume":"129","author":"E Vezzoli","year":"2019","unstructured":"Vezzoli E, Caron I, Talpo F, Besusso D, Conforti P, Battaglia E, Sogne E, Falqui A, Petricca L, Verani M, Martufi P, Caricasole A, Bresciani A, Cecchetti O, di Val R, Cervo P, Sancini G, Riess O, Nguyen H, Seipold L, Saftig P, Biella G, Cattaneo E, Zuccato C (2019) Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington\u2019s disease. J Clin Invest 129:2390\u20132403. https:\/\/doi.org\/10.1172\/JCI120616","journal-title":"J Clin Invest"},{"key":"1379_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228. https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"key":"1379_CR73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/NEN.0b013e31816fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 67:402\u2013416. https:\/\/doi.org\/10.1097\/NEN.0b013e31816fc995","journal-title":"J Neuropathol Exp Neurol"},{"key":"1379_CR74","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/hmg\/ddy363","volume":"28","author":"TE Wood","year":"2019","unstructured":"Wood TE, Barry J, Yang Z, Cepeda C, Levine MS, Gray M (2019) Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model. Hum Mol Genet 28:487\u2013500. https:\/\/doi.org\/10.1093\/hmg\/ddy363","journal-title":"Hum Mol Genet"},{"key":"1379_CR75","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/12729","volume":"23","author":"X Xu","year":"1999","unstructured":"Xu X, Toselli PA, Russell LD, Seldin DC (1999) Globozoospermia in mice lacking the casein kinase II alpha\u2019 catalytic subunit. Nat Genet 23:118\u2013121. https:\/\/doi.org\/10.1038\/12729","journal-title":"Nat Genet"},{"key":"1379_CR76","doi-asserted-by":"publisher","unstructured":"Zarate N, Gundry K, Yu D, Casby J, Eberly LE, \u00d6z G, Gomez-Pastor R (2021) In vivo MR spectroscopy reflects synapse density in a Huntington\u2019s disease mouse model. bioRxiv:2021.2010.2026.465951. doi:https:\/\/doi.org\/10.1101\/2021.10.26.465951","DOI":"10.1101\/2021.10.26.465951"}],"updated-by":[{"DOI":"10.1186\/s40478-022-01397-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000}}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01379-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T07:47:00Z","timestamp":1657093620000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01379-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01379-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.29.359380","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}